Medico Remedies received SOP notices from BSE and NSE alleging non-compliance with SEBI LODR Regulation 6(1).
The company paid fines of ₹63,720 each to BSE and NSE after its waiver applications were rejected.
The company states there is no material financial or operational impact from this regulatory action.
Medico Remedies became compliant with Regulation 6(1) from February 18, 2026, onwards.